284 related articles for article (PubMed ID: 20074015)
1. A new target for proteasome inhibitors: FoxM1.
Gartel AL
Expert Opin Investig Drugs; 2010 Feb; 19(2):235-42. PubMed ID: 20074015
[TBL] [Abstract][Full Text] [Related]
2. FoxM1 is a general target for proteasome inhibitors.
Bhat UG; Halasi M; Gartel AL
PLoS One; 2009 Aug; 4(8):e6593. PubMed ID: 19672316
[TBL] [Abstract][Full Text] [Related]
3. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.
Bhat UG; Halasi M; Gartel AL
PLoS One; 2009; 4(5):e5592. PubMed ID: 19440351
[TBL] [Abstract][Full Text] [Related]
4. FoxM1 inhibitors as potential anticancer drugs.
Gartel AL
Expert Opin Ther Targets; 2008 Jun; 12(6):663-5. PubMed ID: 18479213
[TBL] [Abstract][Full Text] [Related]
5. A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS.
Halasi M; Váraljai R; Benevolenskaya E; Gartel AL
J Biol Chem; 2016 Jan; 291(1):142-8. PubMed ID: 26559972
[TBL] [Abstract][Full Text] [Related]
6. Targeting FOXM1 in cancer.
Halasi M; Gartel AL
Biochem Pharmacol; 2013 Mar; 85(5):644-652. PubMed ID: 23103567
[TBL] [Abstract][Full Text] [Related]
7. FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.
Pandit B; Gartel AL
Cell Cycle; 2011 Oct; 10(19):3269-73. PubMed ID: 21941087
[TBL] [Abstract][Full Text] [Related]
8. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
[TBL] [Abstract][Full Text] [Related]
9. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1.
Radhakrishnan SK; Bhat UG; Hughes DE; Wang IC; Costa RH; Gartel AL
Cancer Res; 2006 Oct; 66(19):9731-5. PubMed ID: 17018632
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors.
Gartel AL
Scientifica (Cairo); 2014; 2014():596528. PubMed ID: 25093142
[TBL] [Abstract][Full Text] [Related]
12. Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.
Wang M; Gartel AL
Mol Cancer Ther; 2011 Dec; 10(12):2287-97. PubMed ID: 21903609
[TBL] [Abstract][Full Text] [Related]
13. Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.
Halasi M; Pandit B; Wang M; Nogueira V; Hay N; Gartel AL
Am J Pathol; 2013 Jul; 183(1):257-65. PubMed ID: 23665201
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors suppress expression of NPM and ARF proteins.
Pandit B; Gartel AL
Cell Cycle; 2011 Nov; 10(22):3827-9. PubMed ID: 22071628
[TBL] [Abstract][Full Text] [Related]
15. Siomycin A Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells by Suppressing the Expression of FoxM1.
Guo X; Liu A; Hua H; Lu H; Zhang D; Lin Y; Sun Q; Zhu X; Yan G; Zhao F
Nat Prod Commun; 2015 Sep; 10(9):1603-6. PubMed ID: 26594769
[TBL] [Abstract][Full Text] [Related]
16. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
[TBL] [Abstract][Full Text] [Related]
17. A novel mode of FoxM1 regulation: positive auto-regulatory loop.
Halasi M; Gartel AL
Cell Cycle; 2009 Jun; 8(12):1966-7. PubMed ID: 19411834
[TBL] [Abstract][Full Text] [Related]
18. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
19. In silico investigation of FOXM1 binding and novel inhibitors in epithelial ovarian cancer.
Chen Y; Ruben EA; Rajadas J; Teng NNH
Bioorg Med Chem; 2015 Aug; 23(15):4576-4582. PubMed ID: 26164623
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.
Uddin S; Hussain AR; Ahmed M; Siddiqui K; Al-Dayel F; Bavi P; Al-Kuraya KS
Haematologica; 2012 Jul; 97(7):1092-100. PubMed ID: 22271891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]